Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.960 +0.340 (+7.36%)
Streaming Delayed Price Updated: 11:13 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exscientia Ltd ADR

< Previous 1 2 3 4 5 6 Next >
Exscientia to Present at Upcoming Investor Conferences in September
From Exscientia plc
Via Business Wire
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
Here are just a few top biotech stocks that may be on the cusp of major, game-changing discoveries, thanks to AI. 
Via InvestorPlace
Exscientia Business Update for Second Quarter and First Half of 2023
From Exscientia plc
Via Business Wire
A Preview Of Exscientia's Earnings
Via Benzinga
3 AI Stocks Billionaires Are Loading Up On
With investors pouring funds into AI, it makes sense to consider snapping up the top AI stocks billionaires buy. 
Via InvestorPlace
The Latest Analyst Ratings for Exscientia
Via Benzinga
4 Analysts Have This to Say About Exscientia
Via Benzinga
Why Shares of Exscientia Soared This Week
The company benefited from a surge in interest in AI-associated stocks. 
Via The Motley Fool
Exscientia: Q1 Earnings Insights
Via Benzinga
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
From Exscientia
Via Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits. 
Via InvestorPlace
MarketBeat Week in Review – 7/24 - 7/28
Investors continue to look for stocks to buy as inflation cools. As you prepare for another busy week, here are some of our top stories from this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Via Benzinga
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
From Exscientia
Via Business Wire
3 Biotech Stocks Using AI to Change Healthcare Forever
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
Why Shares of Exscientia Jumped on Wednesday
The company may be riding the wave of an AI healthcare boom. 
Via The Motley Fool
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours
From Exscientia plc
Via Business Wire
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Exscientia Announces Expansion of its Technology Leadership Team
From Exscientia
Via Business Wire
Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Exscientia plc
Via Business Wire
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
Via InvestorPlace
Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today
With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede. 
Via The Motley Fool
Exscientia Business Update for First Quarter 2023
From Exscientia plc
Via Business Wire
Earnings Scheduled For May 24, 2023
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.